Healthcare
Innovative Midfoot Solutions
October 22, 2026
More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution
More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution
abioSCOPE® is point-of-care platform that measures a biomarker that may begin rising 48 to 72 hours before a clinical diagnosis for sepsis
HOPPR AI is solving the radiology bottleneck by building the foundational infrastructure layer for the next generation of medical imaging AI
OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.
Beren Therapeutics is developing a new class of medicines targeting numerous neurodegenerative diseases, including Alzheimer’s.
A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease
HDT Bio is developing a new immune-maintenance therapy for breast cancer patients designed to prevent relapse years after successful treatment.
A first-in-class oral therapy for cancer, neuroinflammatory, and autoimmune disease with both FDA Fast Track and Orphan Drug designations
Kesmalea is developing an oral therapeutic designed to selectively eliminate a protein strongly associated with Alzheimer’s progression
SonicTrek is launching an AI-powered platform that enable creators to operate personalized 24/7 audio channels in their own voice.
OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.
SonicTrek uses AI to make radio more local by delivering customized programming, localized on-air content, and market-specific personalities at a fraction of the cost